These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 34890937)
21. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma. Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534 [TBL] [Abstract][Full Text] [Related]
22. A CT-based radiomics nomogram for differentiation of squamous cell carcinoma and non-Hodgkin's lymphoma of the palatine tonsil. Dong C; Zheng YM; Li J; Wu ZJ; Yang ZT; Li XL; Xu WJ; Hao DP Eur Radiol; 2022 Jan; 32(1):243-253. PubMed ID: 34236464 [TBL] [Abstract][Full Text] [Related]
23. Can PD-L1 expression be predicted by contrast-enhanced CT in patients with gastric adenocarcinoma? a preliminary retrospective study. Gu X; Yu X; Shi G; Li Y; Yang L Abdom Radiol (NY); 2023 Jan; 48(1):220-228. PubMed ID: 36271155 [TBL] [Abstract][Full Text] [Related]
24. Radiomics Features on Enhanced Computed Tomography Predict FOXP3 Expression and Clinical Prognosis in Patients with Head and Neck Squamous Cell Carcinoma. Wang Y; Ye J; Zhou K; Chen N; Huang G; Feng G; Zhang G; Gou X J Imaging Inform Med; 2024 Aug; 37(4):1323-1335. PubMed ID: 38376584 [TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Model Using Radiomics Features from an Apparent Diffusion Coefficient Map to Diagnose Local Tumor Recurrence in Patients Treated for Head and Neck Squamous Cell Carcinoma. Kim M; Lee JH; Joo L; Jeong B; Kim S; Ham S; Yun J; Kim N; Chung SR; Choi YJ; Baek JH; Lee JY; Kim JH Korean J Radiol; 2022 Nov; 23(11):1078-1088. PubMed ID: 36126954 [TBL] [Abstract][Full Text] [Related]
26. Prediction of the Ki-67 expression level in head and neck squamous cell carcinoma with machine learning-based multiparametric MRI radiomics: a multicenter study. Chen W; Lin G; Chen Y; Cheng F; Li X; Ding J; Zhong Y; Kong C; Chen M; Xia S; Lu C; Ji J BMC Cancer; 2024 Apr; 24(1):418. PubMed ID: 38580939 [TBL] [Abstract][Full Text] [Related]
27. Radiomics Study for Predicting the Expression of PD-L1 and Tumor Mutation Burden in Non-Small Cell Lung Cancer Based on CT Images and Clinicopathological Features. Wen Q; Yang Z; Dai H; Feng A; Li Q Front Oncol; 2021; 11():620246. PubMed ID: 34422625 [TBL] [Abstract][Full Text] [Related]
28. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy. Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403 [TBL] [Abstract][Full Text] [Related]
29. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status. Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683 [TBL] [Abstract][Full Text] [Related]
30. [Bioinformatics analysis of programmed cell death ligand 1 co-expression genes and their regulatory network in head and neck squamous cell carcinoma]. Yang LS; Shi CY; Liang YH; Liu T; Hou XR; Tian XD; Wang XY Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Oct; 37(5):516-520. PubMed ID: 31721500 [TBL] [Abstract][Full Text] [Related]
31. Associations of Tumor PD-1 Ligands, Immunohistochemical Studies, and Textural Features in Chen RY; Lin YC; Shen WC; Hsieh TC; Yen KY; Chen SW; Kao CH Sci Rep; 2018 Jan; 8(1):105. PubMed ID: 29311707 [TBL] [Abstract][Full Text] [Related]
32. Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma. Ngamphaiboon N; Chureemas T; Siripoon T; Arsa L; Trachu N; Jiarpinitnun C; Pattaranutaporn P; Sirachainan E; Larbcharoensub N Med Oncol; 2019 Jan; 36(2):21. PubMed ID: 30666437 [TBL] [Abstract][Full Text] [Related]
33. The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapy. Chen Y; Ding X; Bai X; Zhou Z; Liu Y; Zhang X; Yu J; Hu M Int Immunopharmacol; 2023 Jul; 120():110329. PubMed ID: 37207445 [TBL] [Abstract][Full Text] [Related]
34. Expression of PD-1/PD-L1 in head and neck squamous cell carcinoma and its clinical significance. Chen SW; Li SH; Shi DB; Jiang WM; Song M; Yang AK; Li YD; Bei JX; Chen WK; Zhang Q Int J Biol Markers; 2019 Dec; 34(4):398-405. PubMed ID: 31674884 [TBL] [Abstract][Full Text] [Related]
35. A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning. Kawahara D; Murakami Y; Tani S; Nagata Y Br J Radiol; 2021 Aug; 94(1124):20210525. PubMed ID: 34235955 [TBL] [Abstract][Full Text] [Related]
36. Development of a machine learning-based radiomics signature for estimating breast cancer TME phenotypes and predicting anti-PD-1/PD-L1 immunotherapy response. Han X; Guo Y; Ye H; Chen Z; Hu Q; Wei X; Liu Z; Liang C Breast Cancer Res; 2024 Jan; 26(1):18. PubMed ID: 38287356 [TBL] [Abstract][Full Text] [Related]
37. Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients. Yuan G; Song Y; Li Q; Hu X; Zang M; Dai W; Cheng X; Huang W; Yu W; Chen M; Guo Y; Zhang Q; Chen J Front Immunol; 2020; 11():613946. PubMed ID: 33488622 [TBL] [Abstract][Full Text] [Related]
38. Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset. Dai D; Guo Y; Shui Y; Li J; Jiang B; Wei Q Front Mol Biosci; 2021; 8():775562. PubMed ID: 34970597 [No Abstract] [Full Text] [Related]
39. The clinicopathological significance of PD-L1 expression assessed by the combined positive score (CPS) in head and neck squamous cell carcinoma. Wusiman D; Guo L; Huang Z; Li Z; Liu S; Ying J; Li W; An C Pathol Res Pract; 2022 Aug; 236():153934. PubMed ID: 35691098 [TBL] [Abstract][Full Text] [Related]
40. A Novel Approach Using FDG-PET/CT-Based Radiomics to Assess Tumor Immune Phenotypes in Patients With Non-Small Cell Lung Cancer. Zhou J; Zou S; Kuang D; Yan J; Zhao J; Zhu X Front Oncol; 2021; 11():769272. PubMed ID: 34868999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]